- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-36/17: Action brought on 23 January 2017 — Forest Pharma v EUIPO — Ipsen Pharma (COLINEB)
ECLI:EU:UNKNOWN:62017TN0036
62017TN0036
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C 70/31
(Case T-36/17)
(2017/C 070/40)
Language in which the application was lodged: English
Parties
Applicant: Forest Pharma BV (Amsterdam, Netherlands) (represented by: T. Holman, Solicitor)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Ipsen Pharma SAS (Boulogne Billancourt, France)
Details of the proceedings before EUIPO
Applicant: Applicant
Trade mark at issue: EU word mark ‘COLINEB’ — Application for registration No 13 191 671
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 13 October 2016 in Case R 500/2016-5
Form of order sought
The applicant claims that the Court should:
—annul the contested decision;
—order EUIPO to pay the costs.
Plea in law
—Infringement of Article 8(1)(b) of Regulation No 207/2009.